Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - CEREBAIN BIOTECH CORP.Financial_Report.xls
10-Q - MARCH 31, 2012 10-Q - CEREBAIN BIOTECH CORP.f10q033112_10q.htm
EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATIONS - CEREBAIN BIOTECH CORP.f10q033112_ex31z1.htm

EXHIBIT 32.1



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Discount Dental Materials, Inc. (the "Company") on Form 10-Q for the period ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Gerald DeCiccio, President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:


(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: May 15, 2012



                                 By: /s/ GERALD DECICCIO                              

                                         Gerald DeCiccio

                                         President (Principal Executive Officer and Principal Financial and Accounting Officer)



A signed original of this written statement required by Section 906 has been provided to Discount Dental Materials, Inc. and will be retained by Discount Dental Materials, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.